Handelsavisen
prelaunch
Companies Healthcare GVS.MI
GV
GVS.MI Borsa Italiana Health Care Equipment & Supplies

GVS SpA

€4,43
Open in Charts → Attach watcher ⌖
EUR
Set alert
Last 30 days
1D5D1M3M6MYTD1Y5YMax
Live price chart loads from the market-data widget.
Mcap
831,4M EUR
P/E
29,5x
EV / Rev
2,7x
Div yield
Op margin
13,5 %
ROE
6,4 %
Net margin
6,6 %
Debt / equity
0,71
Beta
52w range
Volume
Day range
Prev close
Open
Next earnings
Ex-dividend
TR 1Y
About

GVS SpA operates in the Health Care Equipment & Supplies industry, generating revenue through the provision of healthcare-related products and services.

Business. GVS SpA (GVS.MI) is a health care equipment and supplies company that operates within the medical device industry. The firm is headquartered in Italy and is primarily listed on the Borsa Italiana. Specific details regarding its operating segments and geographic revenue mix are not provided in the available data.

Classification85 %
SectorHealth Care
Industry groupHealth Care Equipment & Supplies
Generated · model-assisted
Sell-side consensus
BUY5 analysts
3 buy2 hold0 sell
Avg 12m price target5,14

Analyst recommendations

5 analysts · consensus Buy
Buy3
Hold2
Sell0
12-month price target
5,14
Consensus of sell-side coverage.
Upcoming events
— missing data
See all catalysts →

At a glance

Score
not yet scored
Valuation
29,5x
P/E
Analysts
Buy
5 analysts · indicative
Ownership
not yet wired
Profitability
6,4 %
return on equity
Quality
not yet scored

What drives this business

The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.

— missing data

News & coverage

0
  • No recent newsroom coverage mentioning GVS.
  • Sector rotation

    Sector1D1Mvs mkt
    Materials+2,3 %+6,6 %+1,7 %
    Communication Services+2,2 %−5,5 %+1,6 %
    Energy+0,6 %+3,3 %+0,0 %
    Health Care · THIS SECTOR+0,6 %−0,8 %+0,0 %
    Information Technology+0,6 %+6,7 %+0,0 %
    Consumer Discretionary+0,4 %+7,6 %−0,2 %
    Financials−0,3 %−2,8 %−0,9 %
    Consumer Staples−0,4 %+2,5 %−1,0 %
    Real Estate−0,7 %+10,9 %−1,3 %
    Industrials−1,9 %−3,1 %−2,5 %
    Utilities−1,9 %+28,2 %−2,5 %

    Developing storylines

    No tracked sagas currently linked to GVS.MI. Browse all sagas →

    Analysis

    AI analysis
    Generated · analysis pipeline · tier hybrid · as of 2026-08-04 ↑ At a glance

    Opportunity

    — missing data

    Upcoming catalysts

    Scheduled public events. Informational only — not investment advice.

    • Macro
    • Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
    • Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
    • Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
    • Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
    • Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
    • Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
    • Macro & political
    • ElectionSE Swedish Election2026-09-14 · SE
    • ElectionUS U.S. Midterms2026-11-03 · US
    • ElectionFR French Legislative2027-06-01 · FR

    Pre-earnings brief

    — missing data

    Signals & dispatch

    peak dispatch · —

    Composite-score breakdown

    Synthesis

    Business

    GVS SpA (GVS.MI) is a health care equipment and supplies company that operates within the medical device industry. The firm is headquartered in Italy and is primarily listed on the Borsa Italiana. Specific details regarding its operating segments and geographic revenue mix are not provided in the available data.

    Classification85 %
    SectorHealth Care
    Industry groupHealth Care Equipment & Supplies
    AI synthesis
    GENERATED

    GVS SpA maintains a capital structure characterized by significant leverage, with long-term debt of EUR 311.3 million against total equity of EUR 437.2 million, resulting in a debt-to-equity ratio of 0.71. The company holds minimal cash and equivalents of EUR 11,000, leading to a negative net cash position after subtracting total debt. Liquidity is assessed as medium, supported by a current ratio of 1.2, which indicates adequate short-term asset coverage for liabilities but limited buffer. The market capitalization stands at EUR 823.9 million, reflecting a price-to-book ratio of 1.88 and an enterprise value-to-EBITDA multiple of 19.96.

    Profitability metrics indicate modest returns, with a return on equity of 6.4% and a return on assets of 3.2%. The company generated operating income of EUR 57.0 million on revenue of EUR 424.7 million, yielding an operating margin of approximately 13.4%. Net income was EUR 18.4 million, resulting in a net margin of roughly 4.3%. The price-to-earnings ratio of 29.45 suggests the market is pricing in future growth or stability despite current moderate profitability levels. Free cash flow is negligible at EUR 99,000, driven by high capital expenditures of EUR 63.6 million against operating cash flow of EUR 74.9 million.

    Key takeaways
    • GVS SpA carries significant debt with a debt-to-equity ratio of 0.71 and minimal cash reserves, resulting in a negative net cash position.
    • Profitability is modest with a 6.4% ROE and 3.2% ROA, supported by a 13.4% operating margin.
    • Free cash flow is nearly zero due to high capital expenditures relative to operating cash flow.
    • Analyst sentiment is moderately positive with a mean price target of EUR 5.14 and a mean recommendation of 2.20.
    • Dilution risk is low, with no difference between basic and diluted share counts.
    • Liquidity is medium, with a current ratio of 1.2 providing adequate but not robust short-term coverage.

    Bull / Bear case

    Generated · model-assisted
    BULL CASE · 5

    Revenue grew at a 5.9% CAGR over four years, demonstrating consistent top-line expansion despite recent volatility.

    Operating income increased 1.4% year-over-year in FY2026, indicating resilience in core operational profitability.

    Long-term debt decreased to EUR 311.3 million in FY2026, reflecting a deliberate deleveraging strategy.

    The company maintains a moderate debt-to-equity ratio of 0.71, suggesting manageable leverage levels.

    Dilution risk is assessed as low, protecting existing shareholders from significant equity erosion.

    BEAR CASE · 2

    The company faces high credit risk, indicating potential challenges in debt servicing or default.

    Medium liquidity risk flags suggest potential difficulties in meeting short-term financial obligations.

    In focus — financials by report

    Quarterly
    Annual
    QUARTERLYFiled 2026-05-14
    Q1 2026 · Quarter highlights

    Revenue €105.0M, −2,1% YoY; Operating income −1,0% YoY.

    Revenue€105.0M−2,1 % YoY
    Operating income€13.8M−1,0 % YoY
    Net income€11.4M+507,6 % YoY
    Free cash flow€15.8M+231,4 % YoY
    EPS
    Operating cash flow€802.0k−91,3 % YoY
    Financials
    Income statement
    Revenue€105.0M
    Gross profit€60.5M
    Operating income€13.8M
    Net income€11.4M
    Margins
    Gross margin57.7%
    Operating margin13.1%
    Net margin10.9%
    FCF margin15.0%
    Balance sheet
    Total assets€924.9M
    Total liabilities€469.6M
    Total equity€455.3M
    Cash & equivalents€101.6M
    Long-term debt€348.4M
    Cash flow
    Operating cash flow€802.0k
    CapEx-€7.1M
    Free cash flow€15.8M
    SBC
    P&L flow · revenue → net income
    Revenue €105.0MOperating costs €91.2MTax €2.4MNet income €11.4M
    Highlights
    • Revenue €105.0M, −2,1% YoY
    • Operating income −1,0% YoY
    • Net income +507,6% YoY
    • Free cash flow +231,4% YoY
    • Net margin 10.9%

    Valuation TTM

    Market price
    €4,43
    Market cap
    €823.9M
    Enterprise value
    €1.14B
    P/E
    29.5x
    Non-GAAP P/E
    EV / Revenue
    2.7x
    EV / Op income
    20.0x
    EV / OCF
    15.2x
    P / B
    1.9x
    P / Tangible book
    1.9x
    Tangible book
    €437.2M
    Net cash
    -€311.3M
    Current ratio
    1.2
    Debt / equity
    0.7
    ROA
    3.2%
    ROE
    6.4%
    Cash conversion
    268.0%
    CapEx / revenue
    -15.1%
    SBC / revenue
    Dilution ratio
    0.0%

    Revenue by segment

    Market share

    — missing data

    Business relationships

    — missing data

    Supply chain

    — missing data

    Peer comparison

    — missing data

    Market position

    Stress test

    — missing data

    Predictor forecast

    Next quarternear-term
    Earnings · next quarterconf 45 %
    EPS
    Consensus EPS
    0,26
    Predicted surprise
    +0,00
    Beat probability
    45 %
    Analysts
    5
    Other metrics
    Revenue
    no estimate
    Segment revenue
    no estimate
    Margin
    no estimate
    Segment margin
    no estimate
    as of 2026-07-22 · Earnings Surprise V1
    Period note: consensus is not fiscal-period-aligned at source — read as consensus vs the last reported actual, not a calibrated same-quarter surprise.
    Full fiscal year~1 year ahead
    Full fiscal year · our forecast vs guidance vs consensus
    MetricOur forecastGuidanceConsensus
    EPSno estimateno estimate0,26
    Revenueno estimateno estimate432,6M EUR
    Operating incomeno estimateno estimate72,0M EUR
    Full-year consensus mean (period as reported by source) · consensus in EUR. Company-level full-year forecast and management guidance are not yet modelled at scale — shown as "no estimate", never inferred.
    Probabilistic model output — not investment advice. · generated 2026-08-04

    Options

    — missing data

    Short squeeze

    — missing data

    Earnings-call key lines

    — missing data

    Consensus distribution

    sell-side coverage
    Recommendation distribution5 analysts
    Strong buy1
    Buy2
    Hold2
    Sell0
    Strong sell0
    12-month price target€5,14 · Median €4,70
    Low €4,30High €7,50
    Operating income · consensus72,0M EUR
    EPS surprise
    −33,5 %
    reported vs consensus · miss
    Revenue surprise
    −1,8 %
    reported vs consensus · miss

    Estimate revisions

    consensus EPS · 26-week trend
    — missing data

    Sell-side observations

    Low€4,30
    Mean€5,14
    Median€4,70
    High€7,50
    Spot€4,43
    +15.9 %implied to mean12-month sell-side price targets · ▲ spot

    Themes

    — missing data

    ESG

    — missing data

    Risk factors

    Dilution riskLow
    Liquidity riskMedium
    Filing-based flags
    • Net cash is negative after subtracting total debt.

    Benchmarks vs cohort

    Op Margin13,5 %Above median
    Net Margin6,6 %Above median
    ROE6,4 %Above median
    Capex / Rev-15,1 %Bottom quartile
    D/E0,71Below median
    Cash Conv2,68Best in class

    Corporate actions / M&A

    — missing data

    FX exposure

    — missing data

    Comparable transactions

    — missing data

    Derivatives & instruments

    — missing data

    Actions

    Ask Handelsavisen

    — missing data
    Data sources
    • Market data
    • Market data cache
    • Issuer disclosures
    • Public news
    • Earnings transcripts
    • Consensus estimates
    • ESG data
    • Reference data
    How metrics are computed
    • Price To Tangible Book
      market_price / (tangible_book_value / shares_outstanding_diluted)
    • Price To Book
      market_price / (adjusted_book_value / shares_outstanding_diluted)
    • Return On Equity
      net_income / total_equity
    • Enterprise Value
      market_cap - net_cash
    • Ev To Revenue
      enterprise_value / revenue
    • Net Cash
      cash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
    Source documents
    • GVS SpA Market data — financials · 2026-07-22
    • GVS SpA Market data — analyst estimates · 2026-07-22
    • GVS SpA Market data — ESG · 2026-07-22

    Ownership & reference

    Leadership

    • Massimo ScagliariniChief Executive Officer, Executive Director

    Insider activity

    — missing data

    Short positioning

    — missing data

    Geographic breakdown

    — missing data
    Listings · one canonical issuer all listings resolve to the canonical
    GVS.MICanonical
    Borsa Italiana · EUR

    Intel & risk

    PredictorBeat prob45 %Surprise+0,00Full forecast →
    peak dispatch · —
    OSINT findings
    Dilution riskLow
    Liquidity riskMedium
    Net cash is negative after subtracting total debt.

    Evidence & claims

    From filings & derived data
    — missing data

    The Thread

    Everything we know, in order
    2026-05-14 12:13 UTCEARNINGSQuarterly results — Q1 2026 Revenue EUR 105.0M · Net EUR 11.4M
    2026-03-26 15:49 UTCEARNINGSQuarterly results — Q4 2025 Revenue EUR 109.1M · Net EUR 9.4M
    2026-03-26 15:49 UTCEARNINGSAnnual results — FY 2026 Revenue EUR 424.7M · Net EUR 18.4M
    2025-11-12 14:51 UTCEARNINGSQuarterly results — Q3 2025 Revenue EUR 100.0M · Net EUR 8.0M
    2025-08-07 19:00 UTCEARNINGSQuarterly results — Q2 2025 Revenue EUR 108.4M · Net EUR -0.9M
    2025-05-15 14:38 UTCEARNINGSQuarterly results — Q1 2025 Revenue EUR 107.2M · Net EUR 1.9M
    2025-03-24 17:06 UTCEARNINGSQuarterly results — Q4 2024 Revenue EUR 106.9M · Net EUR 13.8M
    2025-03-24 17:06 UTCEARNINGSAnnual results — FY 2025 Revenue EUR 428.5M · Net EUR 33.4M
    2024-11-14 18:21 UTCEARNINGSQuarterly results — Q3 2024 Revenue EUR 106.9M · Net EUR 0.5M
    2024-08-08 19:24 UTCEARNINGSQuarterly results — Q2 2024 Revenue EUR 110.9M · Net EUR 9.6M
    2024-03-26 13:14 UTCEARNINGSAnnual results — FY 2024 Revenue EUR 424.7M · Net EUR 13.6M
    2023-03-21 14:10 UTCEARNINGSAnnual results — FY 2023 Revenue EUR 387.6M · Net EUR 24.1M
    2022-03-22 14:26 UTCEARNINGSAnnual results — FY 2022 Revenue EUR 338.1M · Net EUR 67.6M
    The entity's full life in the product — typed, chronological, joined across Newspaper, Platform and Data. Our memory, made visible.
    Sources filings · IR · transcripts · market data · tier hybrid · as of 2026-08-04 Market data · Issuer disclosures · Public news · Earnings transcripts · Consensus estimates · ESG data · Reference data Premium coverage